Cargando…
Cell therapy in vascularized composite allotransplantation
Allograft rejection is one of the obstacles in achieving a successful vascularized composite allotransplantation (VCA). Treatments of graft rejection with lifelong immunosuppression (IS) subject the recipients to a lifelong risk of cancer development and opportunistic infections. Cell therapy has re...
Autores principales: | Anggelia, Madonna Rica, Cheng, Hui-Yun, Lai, Ping-Chin, Hsieh, Yun-Huan, Lin, Chih-Hung, Lin, Cheng-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422067/ https://www.ncbi.nlm.nih.gov/pubmed/35042019 http://dx.doi.org/10.1016/j.bj.2022.01.005 |
Ejemplares similares
-
Preconditioned Mesenchymal Stromal Cells to Improve Allotransplantation Outcome
por: Cheng, Hui-Yun, et al.
Publicado: (2021) -
Abstract 53: Regulatory T Cells Promote Tolerance during the Early Post-Operative Period in Murine Osteomyocutaneous Vascularized Composite Allotransplantation
por: Anggelia, Madonna R., et al.
Publicado: (2019) -
The intragraft vascularized bone marrow induces secondary donor-specific mystacial pad allograft tolerance
por: Lin, Cheng-Hung, et al.
Publicado: (2022) -
Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation
por: Anggelia, Madonna Rica, et al.
Publicado: (2022) -
Bioimaging of alloantigen-stimulated regulatory T cells in rat vascularized composite allotransplantation
por: Cheng, Hui-Yun, et al.
Publicado: (2018)